Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PTIX......................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
PTIX............................https://stockcharts.com/h-sc/ui?s=PTIX&p=W&b=5&g=0&id=p86431144783
It’s getting there
Buy the dip, Back to $1.40 in a month.
Looks like insiders got some news. Dollar will fall.
Do you think this company is going to start trails in February?
Whats the deal with this company now anyone know?
Hey, I read through most of your post on the board here. Any ideas where this company stands today? Came across my radar and it seems they are still in IND phase. Interested to hear what you think, thanks in advance!
Hey clay is here! This is when you know it’s a pump and dump. Stay away.
PTIX hits $4.06 pre market short squeeze. More to come.
* * $PTIX Video Chart 05-10-2021 * *
Link to Video - click here to watch the technical chart video
Buying the dips there awhile ago paid off nicely. Loved the swings today.
Not a good look for the underwriter. Sold units of stock plus warrant priced at $4.15 (warrant at 120% of that), stock price plunges 50% on NASDAQ. Pretty sure their customers aren't happy.
Been watching all day for bottom. I think we're there.
PTIX moved to the Nasdaq from the OTC:
https://otce.finra.org/otce/dailyList?viewType=Deletions
There is a vote today:
To ratify the appointment of MaloneBailey, LLP as our independent registered public accounting firm for the year ending December 31, 2020.
Many thanks, I think this is also a reputable ringtone site you should know https://toqueparacelular.net/
Many thanks, I think this is also a reputable ringtone site you should know https://toqueparacelular.net/
..is ABBA even still around? #ATRAIN4EVER lol
Keep hanging in there guys. You may want to tell your neighbors to buy as well.
https://www.stepchange.org/debt-info/debt-collection/can-debts-be-sold-on.aspx
If a companies piggy backed credit falls into the rears they the corporation that is piggy backed can sell there debt. This piggy backed credit will show up as a loss and partial tax gain.
The collateral is the credit pre taxed. If the credit is sold at a loss it shows up in the financials as a sharehlolders deficit. The money paid for the credit showes up as a tax credit for the money lost as well the tax on the credit sold as a net revenue.
If the debt holder had paid the creditors then only money on profit is taxed.
So selling the credit to a third party automatically sets up a tax credit for the full amount offered by the third party purchaser of the credit.
You cannot defer the tax’s as in the case of a direct payment from the debtor.
The reason for this is that there must be a way to separate the third party expenses.
Banks do this all time. It’s called accurred accounting. Accounting that shows all relative losses as they are presented.
Do your own DD. Don’t take anyone’s word not even ours.
If everyone felt that way then your assumption is correct. The company is selling equity at far less to raise capital too cover there debt slowly diluting the five dollar interest you mentioned. It’s what comes out of the capital raised that is important boasting the retained earnings from the selling of the debt.
So Sly because of this private placement we the early investors are not fully engaged in the collateral offering. I can only assume then there are others. This of course has let us participate in trading only a small portion of our interest. Will we be included in the second offering to hold an annuity position larger then the one we hold now?
I wouldn’t part with my interest for less then $5 a share. How do you feel about that?
Private placements of collateral for debt are very complex and are often if not always paid through equity dilution.
When paid in capital through retained earnings ie: the issuing of equity paper too the ones who put up the collateral for the debt by the means of restricted shares known as outstanding shares then trade there debt with the banks debt and the bank then sells the collateral or debt too new investors.
The investors who last bought the issued revolving debt then become the new collateral holders.
The question then arises what of the interest of the previous collateral holders. They in fact become unsecured creditors to the company ie: holders of treasury stock.
If there is no treasury then there interest has been abolished or removed. Held in trust by the government as a part of the tax debt owed to be paid by depreciated assets if and only if those costs can be forwarded to the customer or client of the service offered ie: retained earnings for the sale of equity above the capital cost of the equities par value.
You scratch his back the next group will scratch yours.
Private placement will be carried out shortly. The way this often works is collateral will be put up for debt too sell equity. The person putting up the equity ie: placement for collateral. The money raised will be used too return capital to the debt holders. The ones who put up the collateral will be paid an administration fee for the use of the collateral and will share that gain with the new stake holders.
https://www.thebalance.com/what-is-an-alienation-clause-1798510
Make sure you understand all the finer details of the contract to lease.
Mmmmm, so you say.
There always set up as a lease to purchase. Meaning the equity is leased and the shares purchased back from the proceeds of the lease for the original stakeholders. Any new capital raised goes toward the equity purchase.
There is tax’s for the sale and purchase as well the generated revenue from leasing the interest. Any capital depreciation on the assets leased are reimbursed back to both parties involved. One as a notable tax savings or credit that will go toward the purchase off setting the companies tax’s owed ie: treasury minus shareholders deficit.
The lease costs take into account the recievables and payables. Liability is made up of all debt including the lease payments required. If the lease contract to purchase expires as stated in the perspective and articles of incorporation and is not renewed or fully fulfilled then proceeds will be returned minus any depreciated asset costs, and tax’s owed plus any shareholders deficit “ capital borrowed too full fill the lease obligations”.
This is the way it works. Hang on for the ride of your live. There are three entities involved. Government, Bank and the company it self.
The government represents the public interest and appoints a board of directors to oversee spending.
The bank underwrites the offering by offering a credit contract to the company equity holders.
Let’s stop there and examine what that contract may or maynot have in it.
The company borrows stock from the bank under a written contract with collateral attached. The collateral is in the form of a derivative supported by personal collateral put up by participants.
This could be house, home or other business interest that the bank will use to piggy back from.
The company in the meantime will counter piggy back. The sale of the paper “shares” has to be reported as cost plus profits “ capital surplus and retained earnings” .
Retained earnings is the cost and capital surplus being the earnings above par.
This is all due too the effect of the banks equity being piggy backed and the government acting as the trustees of the investors.
The government will in good faith match dollar too dollar of lending capital for every dollar raised.
It doesn’t always have to be in dollars it could be in facilities and consumable goods.
The government assets are lent to the bank. The bank inturns leases the assets to the company at a profit plus expenses ie ( depreciation) the bank lends back its equity to the company and cause the government is the trustee for the public shares the debt for the lent shares show up on the equity side of the equation in reverse to what they should be. Once the debt is slowly paid then of course the retained earnings will rise and capital surplus will diminish.
Buyer beware, do your own DD and teach your self to follow the money through the appropriate Chanel’s.
Last chance to bail. This is how it works. Removing any revenue generated by the sale of debt and it’s associated debt we can then look at the remaining earnings. The other component you must understand is the collateral that can be a combination of earnings and depreciated assets ( receivables) were the cost will be passed on too future equity holders or the customer.
Let’s look at an example. Let’s say everything is begged, borrowed and stolen. We will use the term stollen from the new future equity players buying the debt.
So the companies laboratories are leased from the university along with the required equipment to carry on the work. The contract wages have been notably set and approved. There is no earnings but there is a substanuale
depreciated future costs that is based on 18% for every depreciated dollar held against future tax earnings for the government.
Now there are individuals who will claim it’s a Ponzi game that if there is no generated revenue from the sale of the debt and paper then there is no revenue so for there is no possible means to pay back the debt. This would be true if there wasn’t the intervention of the government, banks and the manipulation of shares through forward splitting and reverse splitting to implement fractional shares.
Time is compensated for to early investors that all who get involved will pay the same. That is if you don’t trade. If you trade and your good at it then that is a personal up side.
So what is the risk of purchasing a company with no legit revenue? First of if the business does not succeed then the accumulated deficit or depreciated assets can be sold at market value. Market value is dedermined on the currency rate at the time the assets are put up. You will have much more activity if the dollar is trading lower relative to other currencies in getting a deal done. If you have a high currency rate relative to the historical lows of the currency your trading in chances the market will be stagnant for the selling of depreciated assets.
So folks the last chance to get off board the rising ship is here. There is no telling if it will sink again. There is no legit revenue but there is going to be a wack of ilegit revenue made and that could lead into legit revenue down the road.
A bid for .01 and a ask for $250. That has to be the most ridiculous thing I have ever seen.
https://www.sec.gov/Archives/edgar/data/1022899/000149315218009498/ex99-1.htm
One of the biggest benifits to this drug is it’s ability to calm a cow down while in being transported ect. Adrenaline other wise builds up in the animal. Now of course chickens, pigs ect. Are also effected. Adrenaline build up in animals is one of the greatest spoiler of the animal making it very tough.
To administer a drug too a animal requires less hurdles and subsequent less R&D costs along with a much faster entry into the market place. This application of a new drug too relieve stress in animals could, maybe be ready for licensing.
Hang on and watch the new revenue numbers come out. The new numbers will tell the story. Note all illigite revenue raised by the selling of paper ie: warrants under a class D arrangement purchased by the former listed public interest minus administrative costs for the above mentioned warrants are none dated leaving a convertible offering open that could possibly be filled at a new par value pending future legit revenue from the above mentioned should a deal be made.
There is a huge market as due noted by the mice reaction to the drug in the agriculture industry sector. Do your own DD. Never act on information given that isn’t backed up by a 8K SEC filing.
Well for the ones who attended I’m sure that you were very impressed as I was with what was said along with the future prospect of this company.
Will be interesting to say the least next week.
Once the preliminaries are done with we will be moving forward. Warrants will be exercised adding much needed revenue as well the selling of tax debt ie: converting of the tax debt too equity.
The process does one of two things. The first of course is the tax credit from depreciated assets creates a share holders deficit or credit. The other is the releaving of the tax debt too the new equity holders allowing the tax debt to be transferred goes right to the bottom line of your revenue.
Now yes this does increase the future tax bill but the company has the option of paying the tax’s or opting for another round of financing in selling the newly created tax debt “ treasury stock “
Now we all know it’s not legit revenue in the sense that a product is being sold. What is happening is capital is being built. The company can piggy back by purchasing stock in another company that is creating legit revenue.
This will often show up in your recievable assets as well by taking your gross revenue and subtracting the retained earnings that is your capital surplus minus the tax debt paid. The capital surplus is made up of borrowed capital as well options and warrants that are exercised.
Because capital borrowed is not taxed of yet a tax debt is then applied that can again be sold to the public under an equity offering to raise additional capital. The tax from capital debt can be withheld until the proceeds are used. It is very important to take into account the companies cash position and the future tax debt that can be brought forward ie: treasury stock
There is plenty of simpler ways to express what I said above. The bottom line is there is a huge capital requirement to move the company forward and I hope as a person buying an equity stake understands the importance of supporting those very capital requirements that will be needed to see the company create legit revenue by its own created synergies or by the purchasing of other legit revenue generating avenues.
Don’t let recievables scare you off. Under many private placement situations using various different financial instruments they can hedge them selfs from the liability risk the recievables may hold.
The tax debt is in place to raise the capital you mentioned. They will sell the debt that was accumulated through the sale of equity above its par value. This has set in motion a government credit due too the original bank debt being sold to equity holders with after there previous taxed money used for the purchase.
More debt could be used. I guess time will tell if there is sufficient collateral raised to support the debt. There is a share holders deficit ie: money raised and tax debt sold and lent back to the company. This company needs a legit revenue source as leveraged tax debt is raised and sold further diluting the existing shareholders of there position.
"HOW LONG UNTIL PROTAGENIC THERAPEUTICS CAN REACH DEFINED MILESTONES IN THE DEVELOPMENT OF PT00114?"
Protagenic Therapeutics is committed to advancing its biological expertise to help build a strong presence with novel, first-in-class approaches in the treatment of a variety of psychological and psychiatric diseases. We believe that understanding the biology of disease as well as the mechanism of action of a potential intervention will help facilitate more efficient and speedy clinical development while improving the probabilities of success in clinical trials. We expect our IND-enabling studies to be completed by March 2018, followed by IND submission to the FDA in the 2nd quarter of 2018. If this IND is accepted by the FDA, we anticipate being able to commence Phase I clinical trials in 2018.
http://protagenic.com/investors/investor-faq/
some action could be coming mid-2018
from the 04/05/2018 10K
http://m2compliance.com/hosting/company/PTIX/link_files/2018/04-05-2018/Form10-KA_(04-05-2018)_ProtagenicTherapeuticsInc/Form10-KA.pdf
"(2) In the absence of a licensing opportunity with a large pharmaceutical partner, we may undertake an equity financing in mid-2018, in order to raise $5-10 million in working capital to fund our first two phases of clinical trials. In this event, Management would aim to disclose additional pre-clinical research results prior to or coincident with this possible equity financing, because this would represent a developmental milestone that could increase the value of the Company’s equity in the view of future investors."
Sitting here listening to this song...
Followers
|
467
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
116987
|
Created
|
03/08/11
|
Type
|
Free
|
Moderators |
Protagenic Therapeutics Inc. is a biotechnology company focusing on the discovery and development of novel, naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Our scientists utilize a proprietary search algorithm to identify new bioactive peptides in the genome. With this technology, the Company has created a portfolio of five novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders. The lead product candidate, PT00114, is targeted to inhibit anxiety and depression without interfering with normal brain function. Recent studies report an important relationship between mood disorders and disturbances in neuropeptide circuits of the brain. Therapeutics that target the natural neuropeptide circuits that are responsible for restoring normal emotionality may offer effective and safe new treatment options. An estimated 340 million people worldwide and 21 million people in the United States suffer from major mental disorders including Major Depressive Disorder, Bipolar Disorder and various Anxiety Disorders. The mission of the Protagenic Therapeutics Inc is to provide innovative, safe and effective treatments for anxiety and depression by using natural neuropeptide hormones to restore normal emotionality |
Transfer Agent:
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Tel: 800.937.5449
Fax: 718.236.2641
info@amstock.com
http://www.otcmarkets.com/stock/ATRN/quote
http://www.otcmarkets.com/stock/ATRN/financials
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |